Margaret is a Managing Director with Deloitte Consulting. She’s focused on bringing her experience in research innovation and patient engagement to strengthen nonprofits, as well as federal and commercial life sciences programs. She joined Deloitte from FasterCures, a center of the Milken Institute where she was Executive Director. She also worked at the American Public Health Association on HIV/AIDS issues, and at the Congressional Office of Technology Assessment studying genetics and society. Margaret is a past-president of the Alliance for a Stronger FDA, and was a member of the NIH National Center for Advancing Translational Sciences Advisory Council and the Cures Acceleration Network Review Board. She currently serves on the Board of Act for NIH, the Asthma and Allergy Foundation of America, FasterCures, Friends of Cancer Research, and the Melanoma Research Alliance. Margaret has a Bachelor’s from University of Maryland in Government and Politics and a Master’s from George Washington in Science, Technology and Public Policy.